{"id":"W2910565776","doi":"10.1002/hep.30509","title":"The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis","year":2019,"lang":"en","type":"article","venue":"Hepatology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":259,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Shionogi; GlaxoSmithKline; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb; Gilead Sciences; Falk Foundation","keywords":"Farnesoid X receptor; Cholestasis; Internal medicine; Agonist; Primary sclerosing cholangitis; Gastroenterology; Medicine; Liver injury; Nonsteroidal; Receptor; Chemistry; Biochemistry; Nuclear receptor; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007821267,0.0008857665,0.001952786,0.0003530633,0.0002371426,0.0003914116,0.0004257366,0.0007569639,0.002810674],"category_scores_gemma":[0.0006104088,0.000409053,0.0007912661,0.0002908716,0.0006403842,0.0006283928,0.0001991326,0.001181758,0.0004818508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003186502,"about_ca_system_score_gemma":0.0005177828,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000462282,"about_ca_topic_score_gemma":0.001653482,"domain_scores_codex":[0.999679,0.0001637906,0.00003387643,0.00003560224,0.00003006703,0.00005776038],"domain_scores_gemma":[0.9995893,0.00009535089,0.0001174398,0.00002414378,0.00002163326,0.0001520366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7791241,0.02434191,0.006628025,0.001254407,0.00114015,0.0002613069,0.0001346198,0.0008744817,0.06654647,0.0001320306,0.001243494,0.1183189],"study_design_scores_gemma":[0.4525087,0.5165359,0.02160505,0.00003678122,0.0007444762,0.0002572838,0.00008648021,0.0007969833,0.006259804,0.00008192826,0.001054123,0.00003248468],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953359,0.003177098,0.0001983541,0.0001771566,0.00006960687,0.0003492269,0.0001670419,0.00005223969,0.0004732644],"genre_scores_gemma":[0.9959142,0.001811931,0.0005003125,0.0002588501,0.0001501376,0.0002697083,0.0003316893,0.000006428555,0.0007567661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002810674,"threshold_uncertainty_score":0.009402692,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005518539412070904,"score_gpt":0.2028879298371718,"score_spread":0.1973693904251009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}